Form 4: RGA Executive Advisor Simon Wainwright Receives Equity Grants

Sentiment:

Statement of Changes in Beneficial Ownership


Simon Wainwright, Executive Advisor to the CEO of Reinsurance Group of America, was granted 557 restricted share units and 1,609 stock appreciation rights.

Delay expectedThe filing of the Form 4 was delayed beyond the required two-business-day window following the transaction date of March 19, 2026.Management attributed the delay to an inadvertent administrative error.

Summary

  • Simon Wainwright received a grant of 557 Restricted Share Units (RSUs) on March 19, 2026.
  • Wainwright also received 1,609 Stock Appreciation Rights (SARs) with an exercise price of $200.50.
  • Both the RSUs and SARs vest in three equal annual installments of 33 1/3% starting March 19, 2027.
  • The equity awards are scheduled to be fully vested by March 19, 2029.
  • The filing was submitted to the SEC on April 27, 2026, which was noted as a late submission.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative event. While the equity grant is a standard positive for executive alignment, the late filing is a minor procedural negative.

Positives

  • Equity-based compensation aligns the interests of the Executive Advisor with those of long-term shareholders.
  • The three-year vesting schedule serves as a retention mechanism for key leadership personnel.
  • The exercise price of $200.50 for SARs suggests a baseline valuation for future growth expectations.

Negatives

  • The report was filed late, which represents a technical non-compliance with SEC Section 16(a) reporting deadlines.
  • Administrative errors in regulatory filings can occasionally signal minor internal control or oversight weaknesses.

Risks

  • The value of the Stock Appreciation Rights is entirely dependent on the share price exceeding $200.50, posing a market risk to the executive's realized compensation.
  • Potential for minor regulatory scrutiny due to the self-identified late filing status.

Future Outlook

The executive is incentivized to drive company performance over the next three years to maximize the value of the equity grants, with full vesting occurring in early 2029.

Management Comments

  • This Form 4 is being filed late due to inadvertent administrative error.

Industry Context

StockSavvy.ai notes that equity grants are a standard component of executive compensation in the reinsurance industry, intended to mirror the long-tail nature of the business's liabilities and performance cycles.

Comparison to Industry Standards

  • The three-year ratable vesting schedule is consistent with compensation structures at peer firms such as Everest Group and RenaissanceRe.
  • The use of a mix of RSUs and SARs is a common practice among S&P 500 financial institutions to balance retention with performance-based incentives.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Reporting ComplianceLate filing of Form 4 due to administrative error.2026-04-27Low impact; represents a minor procedural lapse rather than a strategic shift.

Related Party Transactions

  • Grant of equity securities to an executive officer as part of a standard compensation plan.

Stakeholder Impact

  • Shareholders: Minimal impact, though equity grants ensure management is focused on share price appreciation.
  • Employees: No direct impact.

Next Steps

  • Vesting of the first tranche of securities on March 19, 2027.

Key Dates

DateDescription
2026-03-19Date of the equity grant transaction for RSUs and SARs.
2026-04-27Date the Form 4 was filed with the SEC.
2027-03-19Date the first 33 1/3% increment of the equity awards is scheduled to vest.
2029-03-19Date the equity awards will be fully vested.

Keywords

Reinsurance Group of America, RGA, Executive Compensation, Restricted Share Units, Stock Appreciation Rights, Insider Trading, Form 4, Simon Wainwright

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.